SEARCH

SEARCH BY CITATION

References

  • 1
    E.L. Abel. Marihuana: The First Twelve Thousand Years, Plenum Press, New York, 1980.
  • 2
    W.D. Hall, R. Pacula. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge University Press, Cambridge, 2010.
  • 3
    L. Degenhardt, C. Bucello, B. Calabria, P. Nelson, A. Roberts, W.D. Hall et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend. 2011, 117, 85.
  • 4
    UNODC. World Drug Report 2012. United Nations Office on Drugs and Crime, Vienna, 2012.
  • 5
    M. Asbridge, J.A. Hayden, J. Cartwright. Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ 2012, 344, 14.
  • 6
    W.M. Bosker, E.L. Karschner, D. Lee, R.S. Goodwin, J. Hirvonen, R.B. Innis et al. Psychomotor function in chronic daily cannabis smokers during sustained abstinence. PLoS One 2013, 8, e53127.
  • 7
    M. Norberg, J. Mackenzie, J. Copeland. Quantifying cannabis use with the timeline followback approach: A psychometric evaluation. Drug Alcohol Depend. 2012, 121, 247.
  • 8
    W.D. Hall, L. Degenhardt. The adverse health effects of nonmedical cannabis use. Lancet 2009, 374, 1383.
  • 9
    J. Macleod, R. Oakes, A. Copello, I. Crome, M. Egger, M. Hickman et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 2004, 363, 1579.
  • 10
    J. Anthony. Cannabis Dependence: Its Nature, Consequences and Treatment, (Eds: R.A. Roffman, R.S. Stephens). Cambridge University Press, Cambridge, 2006, pp. 58105.
  • 11
    J. Anthony, L. Warner, R. Kessler. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 1994, 2, 244.
  • 12
    W.D. Hall, M. Teesson, M. Lynskey, L. Degenhardt. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the national survey of mental health and well-being. Addiction 1999, 94, 1541.
  • 13
    A. Lichtman, B. Martin. Cannabinoid tolerance and dependence. Handb. Exp. Pharmacol. 2005, 168, 691.
  • 14
    A. Budney, J. Hughes. The cannabis withdrawal syndrome. Curr. Opin. Psychiat. 2006, 19, 233.
  • 15
    WHO. ATLAS on Substance Use (2010): Resources for the Prevention and Treatment of Substance Use Disorders. World Health Organization, Geneva, 2010.
  • 16
    Dutch National Alcohol and Drug Information System. Treatment demand of cannabis clients in outpatient addiction care in the Netherlands (1994–2001). LADIS Bull. 2004 , April, 1-4.
  • 17
    L. Degenhardt, W.D. Hall. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379, 55.
  • 18
    J. Tetrault, K. Crothers, B. Moore, R. Mehra, J. Concato, D. Fiellin. Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Arch. Intern. Med. 2007, 167, 221.
  • 19
    D. Tashkin, G. Baldwin, T. Sarafian, S. Dubinett, M.D. Roth. Respiratory and immunologic consequences of marijuana smoking. J. Clin. Pharmacol. 2002, 42, 71S.
  • 20
    D. Taylor, D. Fergusson, B. Milne, L. Horwood, T. Moffitt, M. Sears et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002, 97, 1055.
  • 21
    M. Pletcher, E. Vittinghoff, R. Kalhan, J. Richman, M. Safford, S. Sidney et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012, 307, 173.
  • 22
    D. Tashkin. Smoked marijuana as a cause of lung injury. Monaldi Arch. Chest Dis. 2005, 63, 93.
  • 23
    S. Aldington, M. Williams, M. Nowitz, M. Weatherall, A. Pritchard, A. McNaughton et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007, 62, 1058.
  • 24
    D. Moir, W. Rickert, G. Levasseur, Y. Larose, R. Maertens, P. White et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol. 2008, 21, 494.
  • 25
    D. Tashkin. in The Health Effects of Cannabis. (Eds: H. Kalant, W. Corrigall, W.D. Hall, R. Smart), Centre for Addiction and Mental Health, Toronto, 1999, pp. 311345.
  • 26
    S. Sidney, C. Quesenberry, G. Friedman, I. Tekawa. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 1997, 8, 722.
  • 27
    Z. Zhang, H. Morgenstern, M. Spitz, D. Tashkin, G. Yu, J. Marshall et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 1071.
  • 28
    M. Hashibe, K. Straif, D. Tashkin, H. Morgenstern, S. Greenland, Z. Zhang. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005, 35, 265.
  • 29
    R. Mehra, B. Moore, K. Crothers, J. Tetrault, D. Fiellin. The association between marijuana smoking and lung cancer: A systematic review. Arch. Intern. Med. 2006, 166, 1359.
  • 30
    J. Berthiller, K. Straif, M. Boniol, N. Voirin, V. Benhaim-Luzon, W.B. Ayoub, et al. Cannabis smoking and risk of lung cancer in men: A pooled analysis of three studies in Maghreb. J. Thorac. Oncol. 2008, 3, 1398.
  • 31
    S. Aldington, M. Harwood, B. Cox, M. Weatherall, L. Beckert, A. Hansell et al. Cannabis use and risk of lung cancer: A case–control study. Eur. Respir. J. 2008, 31, 280.
  • 32
    M. Hashibe, H. Morgenstern, Y. Cui, D. Tashkin, Z. Zhang, W. Cozen et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case–control study. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1829.
  • 33
    R. Jones. Cardiovascular system effects of marijuana. J. Clin. Pharmacol. 2002, 42, 58S.
  • 34
    S. Sidney. Cardiovascular consequences of marijuana use. J. Clin. Pharmacol. 2002, 42, 64S.
  • 35
    M.A. Mittleman, R. Lewis, M. Maclure, J. Sherwood, J. Muller. Triggering myocardial infarction by marijuana. Circulation 2001, 103, 2805.
  • 36
    K. Mukamal, M. Maclure, J. Muller, M. Mittleman. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am. Heart J. 2008, 155, 465.
  • 37
    L. Gottschalk, W. Aronow, R. Prakash. Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological and cardiovascular functioning in angina patients. Biol. Psychiatry 1977, 12, 255.
  • 38
    E. Jouanjus, F. Leymarie, M. Tubery, M. Lapeyre-Mestre. Cannabis-related hospitalizations: Unexpected serious events identified through hospital databases. Brit. J. Clin. Pharmacol. 2011, 71, 758.
  • 39
    N. Solowij. Cannabis and Cognitive Functioning. Cambridge University Press, Cambridge, UK, 1998.
  • 40
    R. Block, D. O'Leary, R. Hichwa, J. Augustinack, L. Ponto, M. Ghoneim et al. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol. Biochem. Behav. 2002, 72, 237.
  • 41
    N. Solowij, N. Pesa. in Marijuana and Madness, (Eds: D. Castle, R.M. Murray, D.C. D'Souza), Cambridge University Press, New York, 2012, pp. 91102.
  • 42
    N. Solowij, R. Stephens, R. Roffman, T. Babor, R. Kadden, M. Miller et al. Marijuana Treatment Project Research Group. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002, 287, 1123.
  • 43
    K. Bolla, K. Brown, D. Eldreth, K. Tate, J. Cadet. Dose-related neurocognitive effects of marijuana use. Neurology 2002, 59, 1337.
  • 44
    H. Pope, A. Gruber, J. Hudson, M. Huestis, D. Yurgelun-Todd. Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 2001, 58, 909.
  • 45
    M. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts, R. Keefe et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. P. Natl. Acad. Sci. USA. 2012, 109, E2657.
  • 46
    J. Hirvonen, R.S. Goodwin, C.T. Li, G.E. Terry, S.S. Zoghbi, C. Morse et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol. Psychiatry 2012, 17, 642.
  • 47
    J. Quickfall, D. Crockford. Brain neuroimaging in cannabis use: A review. J. Neuropsychiatry Clin. Neurosci. 2006, 18, 318.
  • 48
    M. Yücel, N. Solowij, C. Respondek, S. Whittle, A. Fornito, C. Pantelis et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry 2008, 65, 694.
  • 49
    N. Solowij, M. Yucel, V. Lorenzetti, D. Lubman. Marijuana and Madness, (Eds: D. Castle, R.M. Murray, D.C. D'Souza). Cambridge University Press, New York, 2012, pp. 103113.
  • 50
    M. Lynskey, W.D. Hall. The effects of adolescent cannabis use on educational attainment: A review. Addiction 2000, 96, 433.
  • 51
    P. Ellickson, K. Bui, R. Bell, K. McGuigan. Does early drug use increase the risk of dropping out of high school? J. Drug Issues 1998, 28, 357.
  • 52
    L. Horwood, D. Fergusson, M. Hayatbakhsh, J. Najman, C. Coffey, G. Patton et al. Cannabis use and educational achievement: Findings from three Australasian cohort studies. Drug Alcohol Depend. 2010, 110, 247.
  • 53
    D. Kandel. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Cambridge University Press, New York, 2002.
  • 54
    F. Wagner, J. Anthony. Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am. J. Epidemiol. 2002, 155, 918.
  • 55
    D. Fergusson, J. Boden, L. Horwood. The developmental antecedents of illicit drug use: Evidence from a 25-year longitudinal study. Drug Alcohol Depend. 2008, 96, 165.
  • 56
    A. Morral, D. McCaffrey, S. Paddock. Reassessing the marijuana gateway effect. Addiction 2002, 97, 1493.
  • 57
    J. Lessem, C. Hopfer, B. Haberstick, D. Timberlake, M. Ehringer, A. Smolen et al. Relationship between adolescent marijuana use and young adult illicit drug use. Behav. Genet. 2006, 36, 498.
  • 58
    D. Fergusson, J. Boden, L. Horwood. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction 2006, 101, 556.
  • 59
    W.D. Hall, M. Lynskey. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev. 2005, 24, 39.
  • 60
    M. Lynskey, A. Heath, K. Bucholz, W. Slutske. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003, 289, 427.
  • 61
    Advisory Council on the Misuse of Drugs. Cannabis: Classification and Public Health. Home Office, London, 2008.
  • 62
    S. Andréasson, A. Engstrom, P. Allebeck, U. Rydberg. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 1987, 2, 1483.
  • 63
    S. Zammit, P. Allebeck, S. Andréasson, I. Lundberg, G. Lewis. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. Brit. Med. J. 2002, 325, 1199.
  • 64
    E. Manrique-Garcia, S. Zammit, C. Dalman, T. Hemmingsson, S. Andreasson, P. Allebeck. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol. Med. 2012, 42, 1321.
  • 65
    J. van Os, M. Bak, M. Hanssen, R.V. Bijl, R. de Graaf, H. Verdoux. Cannabis use and psychosis: A longitudinal population-based study. Am. J. Epidemiol. 2002, 156, 319.
  • 66
    C. Henquet, L. Krabbendam, J. Spauwen, C. Kaplan, R. Lieb, H. Wittchen et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. Brit. Med. J. 2004, 330, 11.
  • 67
    D. Fergusson, L. Horwood, N. Swain-Campbell. Cannabis dependence and psychotic symptoms in young people. Psychol. Med. 2003, 33, 15.
  • 68
    L. Arseneault, M. Cannon, R. Poulton, R. Murray, A. Caspi, T. Moffitt. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. Brit. Med. J. 2002, 325, 1212.
  • 69
    T. Moore, S. Zammit, A. Lingford-Hughes, T. Barnes, P. Jones, M. Burke et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007, 370, 319.
  • 70
    L. Degenhardt, W.D. Hall, M. Lynskey. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend. 2003, 71, 37.
  • 71
    M. Hickman, P. Vickerman, J. Macleod, J. Kirkbride, P. Jones. Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007, 102, 597.
  • 72
    J. Boydell, J. van Os, A. Caspi, N. Kennedy, E. Giouroukou, P. Fearon et al. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol. Med. 2006, 36, 1441.
  • 73
    V. Ajdacic-Gross, C. Lauber, I. Warnke, H. Haker, R. Murray, W. Rossler. Changing incidence of psychotic disorders among the young in Zurich. Schizophr. Res. 2007, 95, 9.
  • 74
    S. Saha, D. Chant, J. Welham, J. McGrath. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2, e141.
  • 75
    I.I. Gottesman. Schizophrenia Genesis: The Origins of Madness. W. H. Freeman, New York, 1991.
  • 76
    L. Degenhardt, W.D. Hall, M. Lynskey, C. Coffey, G. Patton. in Marijuana and Madness, (Eds: D. Castle, R. Murray, D. D'Souza). Cambridge University Press, New York, 2012, pp. 114128.
  • 77
    E. Manrique-Garcia, S. Zammit, C. Dalman, T. Hemmingsson, P. Allebeck. Cannabis use and depression: A longitudinal study of a national cohort of Swedish conscripts. BMC Psychiatry 2012, 12, 112. DOI: 10.1186/1471
  • 78
    D. Fergusson, L. Horwood. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997, 92, 279.
  • 79
    L. Horwood, D. Fergusson, C. Coffey, G. Patton, R. Tait, D. Smart et al. Cannabis and depression: An integrative data analysis of four Australasian cohorts. Drug Alcohol Depend. 2012, 126, 369.
  • 80
    H. Lai, T. Sitharthan. Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Am. J. Drug Alcohol Abuse 2012, 38, 567.
  • 81
    S. Lev-Ran, F.B. Le, K. McKenzie, T.P. George, J. Rehm. Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates. Psychiatry Res. 2013, DOI:10.1016/j.psychres.2012.12.014
  • 82
    C. Silberberg, D. Castle, D. Koethe. Marijuana and Madness, (Eds: D. Castle, R. Murray, D. D'Souza). Cambridge University Press, New York, 2012, pp. 129136.
  • 83
    C. Henquet, L. Krabbendam, R. de Graaf, M. ten Have, J. van Os. Cannabis use and expression of mania in the general population. J. Affect. Disord. 2006, 95, 103.
  • 84
    A. Beautrais, P. Joyce, R. Mulder. Cannabis abuse and serious suicide attempts. Addiction 1999, 94, 1155.
  • 85
    J. van Ours, J. Williams, D. Fergusson, L. Horwood. Cannabis use and suicidal ideation. J. Health Econ. 2013, 32, 524.
  • 86
    G. Patton, J. Harris, M. Schwartz, G. Bowes. Adolescent suicidal behaviors: A population-based study of risk. Psychol. Med. 1997, 27, 715.
  • 87
    D. Rasic, S. Weerasinghe, M. Asbridge, D. Langille. Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students. Drug Alcohol Depend. 2013, 129, 49.
  • 88
    J. McLaren, W. Swift, P. Dillon, S. Allsop. Cannabis potency and contamination: A review of the literature. Addiction 2008, 103, 1100.
  • 89
    D. Slade, Z. Mehmedic, S. Chandra, M. ElSohly. Marijuana and Madness, (Eds: D. Castle, R. Murray, D. D'Souza). Cambridge University Press, New York, 2012, pp. 3552.